LAMARQUIS SINGER: Open Payments
NPI 1871893990 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 48 payments from 5 companies in 2025. Trend: 2023 $522 · 2024 $822 · 2025 $1,306
Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 19 | $586 |
| ViiV Healthcare Company | 19 | $337 |
| Merck Sharp & Dohme LLC | 8 | $184 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $100 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $100 |
Products named: DOVATO, PIFELTRO, XIFAXAN, Biktarvy, CABENUVA, Yeztugo.
Industry payments across AL — which companies pay providers there.
